A phase II feasibility study of palbociclib in combination with adjuvant endocrine therapy for hormone receptor-positive invasive breast carcinoma
2019 ◽
Vol 30
(9)
◽
pp. 1514-1520
◽
E.L. Mayer
◽
A. DeMichele
◽
H.S. Rugo
◽
K. Miller
◽
A.G. Waks
◽
...
EL Mayer
◽
AM DeMichele
◽
H Guo
◽
KD Miller
◽
HS Rugo
◽
...
2014 ◽
Vol 32
(15_suppl)
◽
pp. TPS654-TPS654
◽
Erica L. Mayer
◽
Adrienne Brana Gropper
◽
Nadine M. Tung
◽
Michaela Jane Higgins
◽
Tiffany A. Traina
◽
...
Yayoi Adachi
◽
Isao Oze
◽
Masataka Sawaki
◽
Masaya Hattori
◽
Akiyo Yoshimura
◽
...
Diana Lambrinoc
◽
Duşceac Roxana
◽
Alexandru Morea
◽
Poiană Cătălina
2016 ◽
Vol 27
(5)
◽
pp. 806-812
◽
N. Zdenkowski
◽
J.F. Forbes
◽
F.M. Boyle
◽
G. Kannourakis
◽
P.G. Gill
◽
...
2013 ◽
Vol 93
(1)
◽
pp. 114-121
◽
Deb Feldman-Stewart
◽
Yolanda Madarnas
◽
Mihaela Mates
◽
Christine Tong
◽
Eva Grunfeld
◽
...
2019 ◽
Vol 15
(2)
◽
pp. 106-107
◽
Harold J. Burstein
◽
Christina Lacchetti
◽
Jennifer J. Griggs
Jongjin Kim
◽
Wonshik Han
◽
Hyeong-Gon Moon
◽
Min Kyoon Kim
◽
Eunshin Lee
◽
...